Viewing StudyNCT00246298



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00246298
Status: TERMINATED
Last Update Posted: 2011-06-10
First Post: 2005-10-28

Brief Title: A Study to Assess the Effectiveness of PROCRIT Epoetin Alfa Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Organization Data

Organization: Johnson Johnson Pharmaceutical Research Development LLC
Class: INDUSTRY
Study ID: CR003220
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Ortho Biotech Products LP INDUSTRY